Gefarnate
- Generic Name
- Gefarnate
- Drug Type
- Small Molecule
- Chemical Formula
- C27H44O2
- CAS Number
- 51-77-4
- Unique Ingredient Identifier
- 1ISE2Y6ULA
Overview
Gefarnate has been investigated for the treatment and prevention of Stomach Ulcer, Duodenal Ulcer, and Cardio-cerebrovascular Disease.
Background
Gefarnate has been investigated for the treatment and prevention of Stomach Ulcer, Duodenal Ulcer, and Cardio-cerebrovascular Disease.
Indication
1.各种原因引起的胃及十二指肠溃疡、急慢性胃炎、胃酸过多、胃灼热、腹胀、消化不良及痉挛； 2.预防因非甾体抗炎药物由于抑制前列腺素合成而引起的严重胃肠道副作用（胃溃疡或胃炎），也可有效防御癌症患者因化疗药物对胃肠道黏膜细胞的破坏而引起的胃肠道副作用（胃肠道不适/出血/溃疡等）。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath